Moolec Science SA (MLEC) Income Statement
MLEC FY2025 at a glance
Fiscal year ended June 30, 2025 · U.S. dollarsMLEC revenue and net income
Where MLEC's revenue goes
FY2025Each bar shows an amount and its share of revenue. MLEC kept −33.4% of revenue as net income.
MLEC profit margins
MLEC growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +5,830.7% | — | — | — |
| Gross profit | +24,024.0% | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
MLEC quarterly EPS vs estimates
Moolec Science beat the analyst EPS estimate in 8 of the last 8 quarters.
MLEC income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $333.6M | $5.6M | $905,049 | $0 | $0 |
| Cost of revenue | $219.6M | $5.2M | $1.0M | $0 | — |
| Gross profit | $114.0M | $472,581 | −$143,305 | $0 | — |
| Research & development | $9.2M | $1.8M | $1.3M | $985,158 | — |
| Sales, general & admin | $115.2M | $7.2M | $47.4M | $2.6M | — |
| Total operating expenses | $124.5M | $9.5M | $6.5M | $3.7M | $13,802 |
| Operating income | −$10.5M | −$9.0M | −$6.7M | −$1.7M | −$13,800 |
| Interest income | $944,186 | $1.4M | $693,027 | $0 | — |
| Interest expense | $41.8M | $1.2M | $160,035 | $2,130 | — |
| Income before taxes | −$170.0M | −$8.3M | −$52.0M | −$93,808 | −$13,802 |
| Income taxes | $6.6M | −$1.0M | −$234,542 | $2,130 | −$206,297 |
| Net income | −$111.5M | −$7.3M | −$51.8M | −$4.5M | −$13,802 |
| EBITDA | −$69.0M | $14.1M | −$51.7M | −$3.7M | −$13,800 |
| EPS (diluted) | −$153.61 | −$1.44 | −$1.57 | −$1.24 | $0.12 |
| Gross margin | 34.2% | 8.4% | −15.8% | — | — |
| Operating margin | −3.1% | −160.8% | −735.2% | — | — |
| Net margin | −33.4% | −130.0% | −5,722.2% | — | — |
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $1.6M | $1.5M | $2.1M | $252,114 | $905,049 | $905,049 | $0 | $0 | $0 | $0 |
| Cost of revenue | $3.3M | $3.3M | $1.5M | $1.6M | $2.0M | $261,245 | $1.0M | — | $0 | $0 | $0 | — |
| Gross profit | −$674,369 | −$674,369 | $14,773 | −$71,643 | $91,743 | −$9,131 | −$143,305 | — | $0 | $0 | $0 | — |
| Research & development | $298,003 | $298,003 | $425,542 | $420,895 | $447,621 | $423,958 | $370,632 | $576,096 | $576,096 | $31,557 | $372,932 | $276,947 |
| Sales, general & admin | $899,551 | $899,551 | $1.6M | $2.0M | $1.6M | $1.5M | $3.4M | $760,984 | $760,984 | $43.1M | $688,541 | $1.0M |
| Total operating expenses | $1.4M | $4.7M | $2.1M | $4.5M | $2.1M | $2.0M | $3.9M | $444,698 | $444,698 | $47.6M | $757,859 | $1.3M |
| Operating income | −$2.1M | −$2.1M | −$2.1M | −$2.9M | −$2.0M | −$2.0M | −$548,389 | −$444,698 | −$444,698 | −$4.9M | −$757,860 | −$1.3M |
| Interest income | — | $346,513 | $346,513 | $346,513 | — | $346,513 | $346,513 | — | — | — | $0 | — |
| Interest expense | $664,020 | $664,020 | $550,170 | $609,884 | $358,828 | $103,390 | $99,419 | — | $0 | $313,384 | $0 | — |
| Income before taxes | −$2.1M | −$2.1M | −$1.9M | −$3.3M | −$1.3M | −$2.0M | −$3.0M | −$358,579 | −$358,579 | −$48.0M | −$597,801 | −$1.5M |
| Income taxes | $280,889 | — | −$27,989 | — | $126,950 | −$235,990 | −$234,542 | −$26,656 | — | −$42.7M | $4,725 | −$872,342 |
| Net income | −$2.4M | −$2.4M | −$1.9M | −$2.5M | −$1.4M | −$1.8M | −$2.7M | −$358,579 | −$358,579 | −$48.0M | −$602,526 | −$1.5M |
| EBITDA | −$1.2M | −$1.3M | −$1.1M | — | −$627,062 | −$1.7M | −$2.9M | −$444,273 | −$444,273 | −$47.6M | −$757,860 | −$2.2M |
| EPS (diluted) | −$0.60 | −$0.06 | −$0.60 | −$0.60 | −$0.04 | −$0.50 | −$0.30 | −$0.11 | −$1.43 | — | −$0.03 | −$0.00 |
| Gross margin | −25.5% | −25.5% | 0.9% | −4.7% | 4.3% | −3.6% | −15.8% | — | — | — | — | — |
| Operating margin | −77.9% | −77.9% | −135.0% | −193.0% | −96.8% | −786.5% | −60.6% | −49.1% | — | — | — | — |
| Net margin | −91.8% | −91.8% | −123.0% | −166.5% | −66.5% | −707.4% | −303.6% | −39.6% | — | — | — | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in MLEC's financial statements (latest annual report filed December 29, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
MLEC financial results
In fiscal year 2025 (ended June 30, 2025), Moolec Science reported revenue of $333.6 million, up 5,830.7% from the year before. It had a net loss of $111.5 million, a net profit margin of −33.4%. Diluted earnings per share came to −$153.61.
See the MLEC stock overview for the latest quote and news, or the MLEC chart for price history and technical indicators.
MLEC income statement FAQ
What is Moolec Science's annual revenue?
Moolec Science reported total revenue of $333.6 million for fiscal year 2025, which ended on June 30, 2025. That was up 5,830.7% from $5.6 million the previous year.
Is Moolec Science profitable?
No. Moolec Science reported a net loss of $111.5 million in fiscal 2025, a net profit margin of −33.4%; its operating margin was −3.1%.
What is Moolec Science's gross margin?
Moolec Science's gross margin was 34.2% in fiscal 2025: for every $100 of revenue, Moolec Science kept $34 after the direct cost of its products and services.
How much does Moolec Science spend on research and development?
Moolec Science spent $9.2 million on research and development in fiscal 2025, 2.8% of revenue.
What are Moolec Science's earnings per share?
Moolec Science earned $-153.61 per diluted share in fiscal 2025, compared with $-1.44 a year earlier.
When does Moolec Science's fiscal year end?
Moolec Science's fiscal year ends in June. The latest annual report covers the year ended June 30, 2025 and was filed on December 29, 2025.